Literature DB >> 2297454

Amiloride disposition in geriatric patients: importance of renal function.

A Somogyi1, D Hewson, M Muirhead, F Bochner.   

Abstract

1. The absorption and disposition of the potassium sparing diuretic amiloride were determined in nine elderly patients aged 71 to 87 years and in eight young (25 to 38 years) subjects following oral administration of 5 mg amiloride HCl daily to steady-state. 2. The maximum and steady-state plasma amiloride concentrations were significantly (P less than 0.05 and P less than 0.001) higher in the elderly patients. The renal clearance of amiloride was lower in the elderly than in young subjects (102 +/- 36 ml min -1 vs 300 +/- 64 ml min-1, P less than 0.001) as was the urinary excretion of amiloride (36 +/- 13 vs 62 +/- 18% of the dose, P less than 0.01). 3. The steady-state plasma amiloride concentration correlated significantly (r2 = 0.61, P less than 0.001) with amiloride renal clearance and with creatinine clearance (r2 = 0.59, P less than 0.001). There was a very strong positive correlation between renal amiloride clearance and creatinine clearance (r2 = 0.76, P less than 0.001). The slope of the regression line was 2.5 indicating substantial proximal tubular secretion of amiloride. 4. Sodium and potassium excretion, along with urine volume were significantly (P less than 0.05) lower in the elderly (by 39, 45 and 34% respectively). 5. The disposition of amiloride was highly dependent on renal function, with higher plasma amiloride concentrations in the elderly reflecting diminished renal function. The dose of amiloride should be titrated to individual response, and the lower potassium excretion in the elderly patients suggests that the dose of amiloride could be reduced in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297454      PMCID: PMC1380054          DOI: 10.1111/j.1365-2125.1990.tb03595.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  23 in total

1.  The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study.

Authors:  J W Rowe; R Andres; J D Tobin; A H Norris; N W Shock
Journal:  J Gerontol       Date:  1976-03

2.  The effects of amiloride during diuretic therapy in elderly subjects.

Authors:  J P MacFarlane; R D Kennedy
Journal:  Age Ageing       Date:  1972-05       Impact factor: 10.668

3.  Kinetics and bioavailability of two formulations of amiloride in man.

Authors:  A J Smith; R N Smith
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

4.  The meetabolism of amiloride hydroloride in man.

Authors:  P Weiss; R M Hersey; C A Dujovne; J R Bianchine
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

5.  Amiloride handling in renal failure.

Authors:  C F George
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

6.  Severe hyperkalaemia with Moduretic.

Authors:  G F Whiting; C J McLaran; F Bochner
Journal:  Med J Aust       Date:  1979-05-05       Impact factor: 7.738

7.  Aging and renal clearance of procainamide and acetylprocainamide.

Authors:  M M Reidenberg; M Camacho; J Kluger; D E Drayer
Journal:  Clin Pharmacol Ther       Date:  1980-12       Impact factor: 6.875

8.  Age and renal clearance of cimetidine.

Authors:  D E Drayer; J Romankiewicz; B Lorenzo; M M Reidenberg
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875

9.  Renal tubule transport and electrolyte effects of amiloride in the chicken.

Authors:  K Besseghir; B Rennick
Journal:  J Pharmacol Exp Ther       Date:  1981-11       Impact factor: 4.030

Review 10.  Drug therapy in the elderly.

Authors:  J G Ouslander
Journal:  Ann Intern Med       Date:  1981-12       Impact factor: 25.391

View more
  7 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 2.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.

Authors:  R W Piepho; K J Fendler
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 4.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 5.  Adverse drug reactions. An overview of special considerations in the management of the elderly patient.

Authors:  L A Brawn; C M Castleden
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 6.  Is dry eye disease the same in young and old patients? A narrative review of the literature.

Authors:  Stefano Barabino
Journal:  BMC Ophthalmol       Date:  2022-02-22       Impact factor: 2.209

Review 7.  Aging: a predisposition to dry eyes.

Authors:  Anushree Sharma; Holly B Hindman
Journal:  J Ophthalmol       Date:  2014-08-14       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.